Felipe Schütz, Larisse Longo, Melina Belén Keingeski, Eduardo Filippi-Chiela, Carolina Uribe-Cruz, Mário Reis Álvares-da-Silva
{"title":"在实验模型中，脂肪吞噬和表观遗传改变与代谢功能障碍相关的脂肪变性肝病进展有关。","authors":"Felipe Schütz, Larisse Longo, Melina Belén Keingeski, Eduardo Filippi-Chiela, Carolina Uribe-Cruz, Mário Reis Álvares-da-Silva","doi":"10.4254/wjh.v16.i12.1468","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Genetic and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis.</p><p><strong>Aim: </strong>To evaluate micro (mi)RNAs and lipophagy markers in an experimental model of metabolic dysfunction-associated steatohepatitis (MASH).</p><p><strong>Methods: </strong>Adult male Sprague Dawley rats were randomized into two groups: Control group (<i>n</i> = 10) fed a standard diet; and intervention group (<i>n</i> = 10) fed a high-fat-choline-deficient diet for 16 weeks. Molecular evaluation of lipophagy markers in liver tissue [sirtuin-1, p62/sequestosome-1, transcription factor-EB, perilipin-2 <i>(Plin2)</i>, <i>Plin3</i>, <i>Plin5</i>, lysosome-associated membrane proteins-2, rubicon, and <i>Cd36</i>], and serum miRNAs were performed.</p><p><strong>Results: </strong>Animals in the intervention group developed MASH and showed a significant decrease in sirtuin-1 (<i>P</i> = 0.020) and p62/sequestosome-1 (<i>P</i> < 0.001); the opposite was reported for transcription factor-EB (<i>P</i> = 0.020), <i>Plin2</i> (<i>P</i> = 0.003), <i>Plin3</i> (<i>P</i> = 0.031), and <i>Plin5</i> (<i>P</i> = 0.005) compared to the control group. There was no significant difference between groups for lysosome-associated membrane proteins-2 (<i>P</i> = 0.715), rubicon (<i>P</i> = 0.166), and <i>Cd36</i> (<i>P</i> = 0.312). The intervention group showed a significant increase in miR-34a (<i>P</i> = 0.005) and miR-21 (<i>P</i> = 0.043) compared to the control. There was no significant difference between groups for miR-375 (<i>P</i> = 0.905), miR-26b (<i>P</i> = 0.698), and miR-155 (<i>P</i> = 0.688).</p><p><strong>Conclusion: </strong>Animals with MASH presented expression changes in markers related to lysosomal stress and autophagy as well as in miRNAs related to inflammation and fibrogenesis, processes that promote MASLD progression.</p>","PeriodicalId":23687,"journal":{"name":"World Journal of Hepatology","volume":"16 12","pages":"1468-1479"},"PeriodicalIF":2.5000,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686535/pdf/","citationCount":"0","resultStr":"{\"title\":\"Lipophagy and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease progression in an experimental model.\",\"authors\":\"Felipe Schütz, Larisse Longo, Melina Belén Keingeski, Eduardo Filippi-Chiela, Carolina Uribe-Cruz, Mário Reis Álvares-da-Silva\",\"doi\":\"10.4254/wjh.v16.i12.1468\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Genetic and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis.</p><p><strong>Aim: </strong>To evaluate micro (mi)RNAs and lipophagy markers in an experimental model of metabolic dysfunction-associated steatohepatitis (MASH).</p><p><strong>Methods: </strong>Adult male Sprague Dawley rats were randomized into two groups: Control group (<i>n</i> = 10) fed a standard diet; and intervention group (<i>n</i> = 10) fed a high-fat-choline-deficient diet for 16 weeks. Molecular evaluation of lipophagy markers in liver tissue [sirtuin-1, p62/sequestosome-1, transcription factor-EB, perilipin-2 <i>(Plin2)</i>, <i>Plin3</i>, <i>Plin5</i>, lysosome-associated membrane proteins-2, rubicon, and <i>Cd36</i>], and serum miRNAs were performed.</p><p><strong>Results: </strong>Animals in the intervention group developed MASH and showed a significant decrease in sirtuin-1 (<i>P</i> = 0.020) and p62/sequestosome-1 (<i>P</i> < 0.001); the opposite was reported for transcription factor-EB (<i>P</i> = 0.020), <i>Plin2</i> (<i>P</i> = 0.003), <i>Plin3</i> (<i>P</i> = 0.031), and <i>Plin5</i> (<i>P</i> = 0.005) compared to the control group. There was no significant difference between groups for lysosome-associated membrane proteins-2 (<i>P</i> = 0.715), rubicon (<i>P</i> = 0.166), and <i>Cd36</i> (<i>P</i> = 0.312). The intervention group showed a significant increase in miR-34a (<i>P</i> = 0.005) and miR-21 (<i>P</i> = 0.043) compared to the control. There was no significant difference between groups for miR-375 (<i>P</i> = 0.905), miR-26b (<i>P</i> = 0.698), and miR-155 (<i>P</i> = 0.688).</p><p><strong>Conclusion: </strong>Animals with MASH presented expression changes in markers related to lysosomal stress and autophagy as well as in miRNAs related to inflammation and fibrogenesis, processes that promote MASLD progression.</p>\",\"PeriodicalId\":23687,\"journal\":{\"name\":\"World Journal of Hepatology\",\"volume\":\"16 12\",\"pages\":\"1468-1479\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-12-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11686535/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4254/wjh.v16.i12.1468\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4254/wjh.v16.i12.1468","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Lipophagy and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease progression in an experimental model.
Background: Genetic and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis.
Aim: To evaluate micro (mi)RNAs and lipophagy markers in an experimental model of metabolic dysfunction-associated steatohepatitis (MASH).
Methods: Adult male Sprague Dawley rats were randomized into two groups: Control group (n = 10) fed a standard diet; and intervention group (n = 10) fed a high-fat-choline-deficient diet for 16 weeks. Molecular evaluation of lipophagy markers in liver tissue [sirtuin-1, p62/sequestosome-1, transcription factor-EB, perilipin-2 (Plin2), Plin3, Plin5, lysosome-associated membrane proteins-2, rubicon, and Cd36], and serum miRNAs were performed.
Results: Animals in the intervention group developed MASH and showed a significant decrease in sirtuin-1 (P = 0.020) and p62/sequestosome-1 (P < 0.001); the opposite was reported for transcription factor-EB (P = 0.020), Plin2 (P = 0.003), Plin3 (P = 0.031), and Plin5 (P = 0.005) compared to the control group. There was no significant difference between groups for lysosome-associated membrane proteins-2 (P = 0.715), rubicon (P = 0.166), and Cd36 (P = 0.312). The intervention group showed a significant increase in miR-34a (P = 0.005) and miR-21 (P = 0.043) compared to the control. There was no significant difference between groups for miR-375 (P = 0.905), miR-26b (P = 0.698), and miR-155 (P = 0.688).
Conclusion: Animals with MASH presented expression changes in markers related to lysosomal stress and autophagy as well as in miRNAs related to inflammation and fibrogenesis, processes that promote MASLD progression.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
